A better approach to monitoring of therapy in von Willebrand disease?
Emmanuel J. Favaloro
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, New South Wales, Australia
DOI
http://dx.doi.org/10.1160/TH08-07-0449